期刊文献+

抗利福平药物性抗体致急性肾功能衰竭1例实验诊断分析 被引量:1

下载PDF
导出
摘要 目的:探索抗利福平药物抗体检测方法,为临床诊断提供参考。方法:采用免疫血清学方法。样品血清与利福平,新鲜补体共孵育,再进行间接抗人球蛋白试验,观察凝集强度。结果:检测结果为存在利福平药物抗体。结论:结合患者间竭性服药史,利福平药物抗体的存在是致急性肾功能衰竭的原发因素。
出处 《中国误诊学杂志》 CAS 2008年第30期7535-7536,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献2

  • 1Muthukunar T.Jayakunar M .Fernando EM,et al. Acute renal failure due to rifampicin: a study of 25 patients[J]. Am J Kidney Dis,2002,40(4) :690-696.
  • 2Salih SB,Kharal M,Qahtani M,et al. Acute Interstitial Nephritis induced by Intermittent use of Rifampicin in Patient with Brucellosis [J]. Saudi J Kidney Dis Transpl,2008 , 19 (3) : 450-452.

同被引文献26

  • 1World Health Organization. Global tuberculosis report 2014 [M]. Geneva:World Health Organization, 2014 .
  • 2World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis [ M ]. WHO/HTM/TB/2014. 11.
  • 3Geneva: World Health Organization ,2014. Kumar R, Shalimar, Bhatia V, et al. Antituberculosis therapy- induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome [J]. Hepatology, 2010, 51 ( 5 ) : 1665-1674.
  • 4Lee WM, Larson AM, Stravitz RT. AASLD position paper: the management of acute liver failure : update 2011 [ J]. Hepatology, 2011, 54(1) :1-22.
  • 5Perwitasari DA, Atthobari J, Wilffert B. Pharmacogenetics of isoniazid-induced hepatotoxlcity [ J ]. Drug Metab Rev, 2014-, ,47 (2) :222-228.
  • 6Metushi IG, Sanders C, Acute Liver Study Group, et al. Detection of anti-isoniazid and anti-eytochrome P450 antibodies in patients with isoniazid-induced liver failure [ J ]. Hepatology, 2014, 59(3) :1084-1093.
  • 7Metushi IG, Lee WM, Uetrecht J. IgG3 is the dominant subtype of anti-isoniazid antibodies in patients with isoniazid-indnced liver failure[ J]. Chem Res Toxicol, 2014, 27(5) :738-740.
  • 8Gupta VH, Amarapurkar DN, Singh M, el al. Association oi" N-acetyhransferase 2 and cytochrome P450 2El gene polymorphisms with antitubereulosis drug-induced hepatotoxicity in Western India[ J]. J GastroenteroI Hepatol, 2013, 28 ( 8 ) : 1368- 1374.
  • 9An HR, Wu XQ, Wang ZY, et al. NAT2 and CYP2E1 polymurphisms associated with antituberculosis drug-induced hepatotoxieity in Chinese patients [ J ]. Clin Exp Phannacol Physiol, 2012, 39(6):535-543.
  • 10Wang PY, Xie SY, Hao Q, et al. NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis[ J]. Int J Tuberc Lung Dis, 2012, 16 ( 5 ) : 589- 595.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部